Evidence map›Paper›PMID 25271011›Full record

Trial reportEuropean journal of clinical nutrition2015

The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial.

M D Kearns, J N G Binongo, D Watson, J A Alvarez, D Lodin, T R Ziegler, V Tangpricha

Erratum issued Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03747523 (Study of the Effect of Ergocalciferol on Plasma and Urinary Mucin-1 Levels in Healthy Individuals and Individuals With Autosomal Dominant Tubulo-Interstitial Kidney Disease Due to MUC1 Mutations), which is not on this map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03747523 early_phase1completednot on this mapstarted 2019, after this paper: background citation

Study of the Effect of Ergocalciferol on Plasma and Urinary Mucin-1 Levels in Healthy Individuals and Individuals With Autosomal Dominant Tubulo-Interstitial Kidney Disease Due to MUC1 Mutations (ADTKD-MUC1)

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2020Enrolled44ConditionsErgocalciferolArmsErgocalciferol
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. High-dose vitamin DClinical nutrition (Edinburgh, Scotland) · 2017
    Trial
  5. Trial
  6. Free 25-Hydroxyvitamin D Concentrations in Cystic Fibrosis.The American journal of the medical sciences · 2015
    Trial
  7. Review
  8. Vitamin D-is the sun enough for us?Nutrition & metabolism · 2025
    Review
  9. Article
  10. A Single Oral Vitamin DInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. The link between vitamin D and COVID-19.Contemporary clinical trials · 2021
    Article
  15. Article
  16. Hypocalcemic Seizure Due to Vitamin D Deficiency.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M D KearnsDivision of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
J N G BinongoDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA, USA.
D WatsonDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA, USA.
J A AlvarezDivision of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
D LodinDivision of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
T R ZieglerDivision of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
V Tangpricha1] Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA [2] Atlanta Veterans Affairs Medical Center, Section of Endocrinology, Atlanta, GA, USA.
Emory University · USVeterans Health Administration · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
ENDOCRINOLOGY, METABOLISM, AND DIABETEST32DK007298 · NIDDK · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 1986 to 2014
$3.2M
Emory Initiative for Maximizing Student DevelopmentR25GM099644 · NIGMS · EMORY UNIVERSITY · PI MARSTELLER, PATRICIA A., WILKINSON, KEITH D · 2013 to 2017
$2.7M
Patient Oriented Research In Clinical NutritionK24DK096574 · NIDDK · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 2012 to 2016
$888k
Role of T-cells in Osteoporosis in Women Undergoing Surgical MenopauseK23AR054334 · NIAMS · EMORY UNIVERSITY · PI TANGPRICHA, VIN · 2007 to 2011
$641k
Integration of Nutritional Metabolomics with Bioenergetics in Cystic FibrosisK01DK102851 · NIDDK · EMORY UNIVERSITY · PI ALVAREZ, JESSICA ALEJANDRA · 2014 to 2018
$614k
NCATS NIH HHS UL1 TR000454NIAMS NIH HHS K23 AR054334NIDDK NIH HHS K01 DK102851NIDDK NIH HHS K24 DK096574NIDDK NIH HHS T32 DK007298NIDDK NIH HHS T32 DK007298-32S1NIGMS NIH HHS R25 GM099644
6 · The paper itself

Abstract

BACKGROUND/

objectivesAlthough single, high doses of vitamin D effectively maintain vitamin D sufficiency in several populations, no studies have evaluated healthy adults over winter, during which vitamin D status declines. This study investigated whether high-dose vitamin D3 given once to healthy adults before winter will (1) prevent the wintertime decline in vitamin D status, (2) promote vitamin D sufficiency 1 year following the dose and (3) prevent the rise of parathyroid hormone (PTH) concentrations. SUBJECTS/

methodsIn this double-blind, placebo-controlled trial, we assessed plasma 25(OH)D and PTH concentrations at baseline, 5, 90 and 365 days after drug administration in 28 healthy adults. In all, >80% of subjects returned at each time point.

resultsAt baseline, the young, healthy participants had a mean plasma 25(OH)D concentration of 17.5±6.1 ng/ml. Only two subjects exhibited plasma 25(OH)D concentrations >30 ng/ml. At 5 days, subjects randomized to vitamin D3 had a higher mean plasma 25(OH)D concentration compared with the placebo group (39.1 vs 19.1 ng/ml, P<0.001). Plasma 25(OH)D concentrations returned to baseline at 90 and 365 days in the vitamin D3 group and remained unchanged in the placebo group. PTH and calcium concentrations were unrelated to changes in 25(OH)D levels and similar between groups over time.

conclusionsA dose of 250,000 IU of vitamin D3 given once in November resulted in a robust increase in plasma 25(OH)D after 5 days, but it was unable to sustain this increase after 90 days. A larger or more frequent dosing regimen may be needed for long-term vitamin D sufficiency.

Indexed as

Dietary SupplementsSeasonsAdultCalciumCholecalciferolDouble-Blind MethodFemaleHealthy VolunteersHumansMaleParathyroid HormoneReference ValuesVitamin DVitamin D DeficiencyVitaminsYoung Adult25-hydroxyvitamin DCalciumCholecalciferolParathyroid HormoneVitamin DVitamins

Identifiers

PMID25271011
PMCPMC4318716
OpenAlexW2036255318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.